nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunitrazepam—UGT2B7—Mycophenolic acid—systemic scleroderma	0.232	0.276	CbGbCtD
Flunitrazepam—UGT1A1—Mycophenolic acid—systemic scleroderma	0.2	0.238	CbGbCtD
Flunitrazepam—UGT2B7—Mycophenolate mofetil—systemic scleroderma	0.129	0.154	CbGbCtD
Flunitrazepam—UGT1A1—Mycophenolate mofetil—systemic scleroderma	0.112	0.133	CbGbCtD
Flunitrazepam—CYP1A2—Pentoxifylline—systemic scleroderma	0.0431	0.0512	CbGbCtD
Flunitrazepam—CYP1A2—Leflunomide—systemic scleroderma	0.0411	0.0489	CbGbCtD
Flunitrazepam—CYP2C9—Leflunomide—systemic scleroderma	0.037	0.044	CbGbCtD
Flunitrazepam—CYP2C19—Prednisone—systemic scleroderma	0.022	0.0262	CbGbCtD
Flunitrazepam—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0133	0.0158	CbGbCtD
Flunitrazepam—CYP3A4—Prednisone—systemic scleroderma	0.0106	0.0126	CbGbCtD
Flunitrazepam—CYP2C9—cardial valve—systemic scleroderma	0.0087	0.335	CbGeAlD
Flunitrazepam—Emotional distress—Pentoxifylline—systemic scleroderma	0.00624	0.0468	CcSEcCtD
Flunitrazepam—Sleep disturbance—Pentoxifylline—systemic scleroderma	0.00473	0.0355	CcSEcCtD
Flunitrazepam—Sleep disturbance—Lisinopril—systemic scleroderma	0.00254	0.0191	CcSEcCtD
Flunitrazepam—Sleep disorder—Pentoxifylline—systemic scleroderma	0.00222	0.0167	CcSEcCtD
Flunitrazepam—TSPO—artery—systemic scleroderma	0.00214	0.0826	CbGeAlD
Flunitrazepam—UGT1A3—digestive system—systemic scleroderma	0.00183	0.0708	CbGeAlD
Flunitrazepam—Delusion—Mycophenolate mofetil—systemic scleroderma	0.00176	0.0132	CcSEcCtD
Flunitrazepam—TSPO—blood vessel—systemic scleroderma	0.00167	0.0643	CbGeAlD
Flunitrazepam—Hiccups—Mycophenolic acid—systemic scleroderma	0.00158	0.0119	CcSEcCtD
Flunitrazepam—Drowsiness—Pentoxifylline—systemic scleroderma	0.00148	0.0111	CcSEcCtD
Flunitrazepam—Sweating—Pentoxifylline—systemic scleroderma	0.00142	0.0107	CcSEcCtD
Flunitrazepam—Sleep disorder—Leflunomide—systemic scleroderma	0.00139	0.0104	CcSEcCtD
Flunitrazepam—Ataxia—Captopril—systemic scleroderma	0.00137	0.0103	CcSEcCtD
Flunitrazepam—Orthostatic hypotension—Captopril—systemic scleroderma	0.00133	0.01	CcSEcCtD
Flunitrazepam—Muscular weakness—Captopril—systemic scleroderma	0.00129	0.00966	CcSEcCtD
Flunitrazepam—Hiccups—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00936	CcSEcCtD
Flunitrazepam—Delusion—Prednisone—systemic scleroderma	0.00119	0.00897	CcSEcCtD
Flunitrazepam—Sleep disorder—Lisinopril—systemic scleroderma	0.00119	0.00896	CcSEcCtD
Flunitrazepam—Psychotic disorder—Mycophenolic acid—systemic scleroderma	0.00112	0.00841	CcSEcCtD
Flunitrazepam—Tremor—Pentoxifylline—systemic scleroderma	0.00109	0.00815	CcSEcCtD
Flunitrazepam—Ataxia—Mycophenolic acid—systemic scleroderma	0.00108	0.0081	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Pentoxifylline—systemic scleroderma	0.00108	0.00808	CcSEcCtD
Flunitrazepam—Agitation—Pentoxifylline—systemic scleroderma	0.00107	0.008	CcSEcCtD
Flunitrazepam—Angioedema—Pentoxifylline—systemic scleroderma	0.00106	0.00795	CcSEcCtD
Flunitrazepam—UGT2B7—digestive system—systemic scleroderma	0.00105	0.0406	CbGeAlD
Flunitrazepam—Orthostatic hypotension—Mycophenolic acid—systemic scleroderma	0.00105	0.00787	CcSEcCtD
Flunitrazepam—Malaise—Pentoxifylline—systemic scleroderma	0.00105	0.00785	CcSEcCtD
Flunitrazepam—Diplopia—Lisinopril—systemic scleroderma	0.00103	0.00776	CcSEcCtD
Flunitrazepam—Muscular weakness—Mycophenolic acid—systemic scleroderma	0.00101	0.00759	CcSEcCtD
Flunitrazepam—Hallucination—Captopril—systemic scleroderma	0.001	0.00754	CcSEcCtD
Flunitrazepam—Irritability—Lisinopril—systemic scleroderma	0.000986	0.0074	CcSEcCtD
Flunitrazepam—Anxiety—Pentoxifylline—systemic scleroderma	0.000983	0.00738	CcSEcCtD
Flunitrazepam—Discomfort—Pentoxifylline—systemic scleroderma	0.000975	0.00732	CcSEcCtD
Flunitrazepam—Ataxia—Lisinopril—systemic scleroderma	0.000971	0.00729	CcSEcCtD
Flunitrazepam—Dry mouth—Pentoxifylline—systemic scleroderma	0.000965	0.00725	CcSEcCtD
Flunitrazepam—Amnesia—Mycophenolate mofetil—systemic scleroderma	0.000963	0.00723	CcSEcCtD
Flunitrazepam—Confusional state—Pentoxifylline—systemic scleroderma	0.000954	0.00716	CcSEcCtD
Flunitrazepam—Orthostatic hypotension—Lisinopril—systemic scleroderma	0.000944	0.00708	CcSEcCtD
Flunitrazepam—Tachycardia—Pentoxifylline—systemic scleroderma	0.000923	0.00693	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Pentoxifylline—systemic scleroderma	0.000915	0.00687	CcSEcCtD
Flunitrazepam—Angioedema—Mometasone—systemic scleroderma	0.000914	0.00686	CcSEcCtD
Flunitrazepam—Diplopia—Mycophenolate mofetil—systemic scleroderma	0.000905	0.0068	CcSEcCtD
Flunitrazepam—UGT1A1—digestive system—systemic scleroderma	0.000896	0.0346	CbGeAlD
Flunitrazepam—Hypotension—Pentoxifylline—systemic scleroderma	0.000884	0.00664	CcSEcCtD
Flunitrazepam—Psychotic disorder—Mycophenolate mofetil—systemic scleroderma	0.000884	0.00664	CcSEcCtD
Flunitrazepam—TSPO—connective tissue—systemic scleroderma	0.000855	0.033	CbGeAlD
Flunitrazepam—Sweating—Mycophenolic acid—systemic scleroderma	0.000847	0.00636	CcSEcCtD
Flunitrazepam—Hiccups—Prednisone—systemic scleroderma	0.000845	0.00635	CcSEcCtD
Flunitrazepam—Somnolence—Pentoxifylline—systemic scleroderma	0.000841	0.00631	CcSEcCtD
Flunitrazepam—Dry mouth—Mometasone—systemic scleroderma	0.000833	0.00625	CcSEcCtD
Flunitrazepam—GABRA4—tendon—systemic scleroderma	0.000831	0.032	CbGeAlD
Flunitrazepam—Orthostatic hypotension—Mycophenolate mofetil—systemic scleroderma	0.000827	0.00621	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Captopril—systemic scleroderma	0.000815	0.00612	CcSEcCtD
Flunitrazepam—Angioedema—Captopril—systemic scleroderma	0.000803	0.00603	CcSEcCtD
Flunitrazepam—Muscular weakness—Mycophenolate mofetil—systemic scleroderma	0.000798	0.00599	CcSEcCtD
Flunitrazepam—Malaise—Captopril—systemic scleroderma	0.000792	0.00595	CcSEcCtD
Flunitrazepam—Hallucination—Mycophenolic acid—systemic scleroderma	0.000789	0.00593	CcSEcCtD
Flunitrazepam—TSPO—smooth muscle tissue—systemic scleroderma	0.000782	0.0302	CbGeAlD
Flunitrazepam—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00078	0.00585	CcSEcCtD
Flunitrazepam—TSPO—skin of body—systemic scleroderma	0.000772	0.0298	CbGeAlD
Flunitrazepam—Sweating—Lisinopril—systemic scleroderma	0.000763	0.00573	CcSEcCtD
Flunitrazepam—Dysarthria—Methotrexate—systemic scleroderma	0.000747	0.00561	CcSEcCtD
Flunitrazepam—Discomfort—Captopril—systemic scleroderma	0.000739	0.00555	CcSEcCtD
Flunitrazepam—Dry mouth—Captopril—systemic scleroderma	0.000731	0.00549	CcSEcCtD
Flunitrazepam—Confusional state—Captopril—systemic scleroderma	0.000723	0.00543	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Azathioprine—systemic scleroderma	0.000711	0.00534	CcSEcCtD
Flunitrazepam—Hallucination—Lisinopril—systemic scleroderma	0.000711	0.00534	CcSEcCtD
Flunitrazepam—Fatigue—Mometasone—systemic scleroderma	0.000704	0.00528	CcSEcCtD
Flunitrazepam—Tachycardia—Captopril—systemic scleroderma	0.0007	0.00525	CcSEcCtD
Flunitrazepam—Malaise—Azathioprine—systemic scleroderma	0.000691	0.00519	CcSEcCtD
Flunitrazepam—Asthenia—Pentoxifylline—systemic scleroderma	0.000679	0.0051	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Leflunomide—systemic scleroderma	0.000672	0.00504	CcSEcCtD
Flunitrazepam—Hypotension—Captopril—systemic scleroderma	0.00067	0.00503	CcSEcCtD
Flunitrazepam—Sweating—Mycophenolate mofetil—systemic scleroderma	0.000669	0.00502	CcSEcCtD
Flunitrazepam—Angioedema—Leflunomide—systemic scleroderma	0.000662	0.00497	CcSEcCtD
Flunitrazepam—Amnesia—Prednisone—systemic scleroderma	0.000653	0.0049	CcSEcCtD
Flunitrazepam—Malaise—Leflunomide—systemic scleroderma	0.000653	0.0049	CcSEcCtD
Flunitrazepam—Tremor—Mycophenolic acid—systemic scleroderma	0.000647	0.00486	CcSEcCtD
Flunitrazepam—Discomfort—Azathioprine—systemic scleroderma	0.000645	0.00484	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.000641	0.00481	CcSEcCtD
Flunitrazepam—Somnolence—Captopril—systemic scleroderma	0.000637	0.00479	CcSEcCtD
Flunitrazepam—Agitation—Mycophenolic acid—systemic scleroderma	0.000635	0.00477	CcSEcCtD
Flunitrazepam—CYP2A6—lung—systemic scleroderma	0.000631	0.0243	CbGeAlD
Flunitrazepam—Dizziness—Pentoxifylline—systemic scleroderma	0.000626	0.0047	CcSEcCtD
Flunitrazepam—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.000623	0.00468	CcSEcCtD
Flunitrazepam—Malaise—Mycophenolic acid—systemic scleroderma	0.000623	0.00468	CcSEcCtD
Flunitrazepam—Fatigue—Captopril—systemic scleroderma	0.000618	0.00464	CcSEcCtD
Flunitrazepam—TSPO—digestive system—systemic scleroderma	0.000618	0.0238	CbGeAlD
Flunitrazepam—Anxiety—Leflunomide—systemic scleroderma	0.000614	0.00461	CcSEcCtD
Flunitrazepam—Discomfort—Leflunomide—systemic scleroderma	0.000609	0.00457	CcSEcCtD
Flunitrazepam—Dry mouth—Leflunomide—systemic scleroderma	0.000603	0.00453	CcSEcCtD
Flunitrazepam—Psychotic disorder—Prednisone—systemic scleroderma	0.000599	0.0045	CcSEcCtD
Flunitrazepam—Rash—Pentoxifylline—systemic scleroderma	0.000596	0.00448	CcSEcCtD
Flunitrazepam—Dermatitis—Pentoxifylline—systemic scleroderma	0.000596	0.00447	CcSEcCtD
Flunitrazepam—Headache—Pentoxifylline—systemic scleroderma	0.000593	0.00445	CcSEcCtD
Flunitrazepam—Feeling abnormal—Captopril—systemic scleroderma	0.000591	0.00444	CcSEcCtD
Flunitrazepam—TSPO—tendon—systemic scleroderma	0.000588	0.0227	CbGeAlD
Flunitrazepam—Anxiety—Mycophenolic acid—systemic scleroderma	0.000586	0.0044	CcSEcCtD
Flunitrazepam—Asthenia—Mometasone—systemic scleroderma	0.000586	0.0044	CcSEcCtD
Flunitrazepam—Irritability—Prednisone—systemic scleroderma	0.000586	0.0044	CcSEcCtD
Flunitrazepam—Hypotension—Azathioprine—systemic scleroderma	0.000585	0.00439	CcSEcCtD
Flunitrazepam—Tremor—Lisinopril—systemic scleroderma	0.000583	0.00438	CcSEcCtD
Flunitrazepam—Discomfort—Mycophenolic acid—systemic scleroderma	0.000581	0.00436	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000577	0.00433	CcSEcCtD
Flunitrazepam—Tachycardia—Leflunomide—systemic scleroderma	0.000577	0.00433	CcSEcCtD
Flunitrazepam—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000575	0.00432	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000571	0.00429	CcSEcCtD
Flunitrazepam—Angioedema—Lisinopril—systemic scleroderma	0.000568	0.00427	CcSEcCtD
Flunitrazepam—Confusional state—Mycophenolic acid—systemic scleroderma	0.000568	0.00427	CcSEcCtD
Flunitrazepam—Malaise—Lisinopril—systemic scleroderma	0.000561	0.00421	CcSEcCtD
Flunitrazepam—Hypotension—Leflunomide—systemic scleroderma	0.000552	0.00415	CcSEcCtD
Flunitrazepam—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00055	0.00413	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000545	0.00409	CcSEcCtD
Flunitrazepam—Muscular weakness—Prednisone—systemic scleroderma	0.000541	0.00406	CcSEcCtD
Flunitrazepam—Anxiety—Lisinopril—systemic scleroderma	0.000528	0.00396	CcSEcCtD
Flunitrazepam—Hypotension—Mycophenolic acid—systemic scleroderma	0.000527	0.00395	CcSEcCtD
Flunitrazepam—Discomfort—Lisinopril—systemic scleroderma	0.000523	0.00393	CcSEcCtD
Flunitrazepam—Dry mouth—Lisinopril—systemic scleroderma	0.000518	0.00389	CcSEcCtD
Flunitrazepam—TSPO—lung—systemic scleroderma	0.000516	0.0199	CbGeAlD
Flunitrazepam—Feeling abnormal—Azathioprine—systemic scleroderma	0.000516	0.00387	CcSEcCtD
Flunitrazepam—Rash—Mometasone—systemic scleroderma	0.000515	0.00386	CcSEcCtD
Flunitrazepam—Asthenia—Captopril—systemic scleroderma	0.000514	0.00386	CcSEcCtD
Flunitrazepam—Dermatitis—Mometasone—systemic scleroderma	0.000514	0.00386	CcSEcCtD
Flunitrazepam—Confusional state—Lisinopril—systemic scleroderma	0.000512	0.00384	CcSEcCtD
Flunitrazepam—Headache—Mometasone—systemic scleroderma	0.000511	0.00384	CcSEcCtD
Flunitrazepam—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000511	0.00383	CcSEcCtD
Flunitrazepam—Fatigue—Leflunomide—systemic scleroderma	0.000509	0.00383	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000506	0.0038	CcSEcCtD
Flunitrazepam—Somnolence—Mycophenolic acid—systemic scleroderma	0.000501	0.00376	CcSEcCtD
Flunitrazepam—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000501	0.00376	CcSEcCtD
Flunitrazepam—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000498	0.00374	CcSEcCtD
Flunitrazepam—Tachycardia—Lisinopril—systemic scleroderma	0.000496	0.00372	CcSEcCtD
Flunitrazepam—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000492	0.00369	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000491	0.00369	CcSEcCtD
Flunitrazepam—Irritability—Methotrexate—systemic scleroderma	0.000489	0.00367	CcSEcCtD
Flunitrazepam—Feeling abnormal—Leflunomide—systemic scleroderma	0.000487	0.00366	CcSEcCtD
Flunitrazepam—Fatigue—Mycophenolic acid—systemic scleroderma	0.000486	0.00365	CcSEcCtD
Flunitrazepam—CYP2C19—digestive system—systemic scleroderma	0.000486	0.0187	CbGeAlD
Flunitrazepam—Ataxia—Methotrexate—systemic scleroderma	0.000482	0.00362	CcSEcCtD
Flunitrazepam—CYP2B6—skin of body—systemic scleroderma	0.000475	0.0183	CbGeAlD
Flunitrazepam—Hypotension—Lisinopril—systemic scleroderma	0.000474	0.00356	CcSEcCtD
Flunitrazepam—Dizziness—Captopril—systemic scleroderma	0.000474	0.00356	CcSEcCtD
Flunitrazepam—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000465	0.00349	CcSEcCtD
Flunitrazepam—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000462	0.00347	CcSEcCtD
Flunitrazepam—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000458	0.00344	CcSEcCtD
Flunitrazepam—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000454	0.00341	CcSEcCtD
Flunitrazepam—Rash—Captopril—systemic scleroderma	0.000452	0.00339	CcSEcCtD
Flunitrazepam—Dermatitis—Captopril—systemic scleroderma	0.000452	0.00339	CcSEcCtD
Flunitrazepam—Somnolence—Lisinopril—systemic scleroderma	0.000451	0.00339	CcSEcCtD
Flunitrazepam—Headache—Captopril—systemic scleroderma	0.000449	0.00337	CcSEcCtD
Flunitrazepam—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000449	0.00337	CcSEcCtD
Flunitrazepam—Fatigue—Lisinopril—systemic scleroderma	0.000438	0.00329	CcSEcCtD
Flunitrazepam—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000434	0.00326	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00043	0.00323	CcSEcCtD
Flunitrazepam—Asthenia—Leflunomide—systemic scleroderma	0.000424	0.00318	CcSEcCtD
Flunitrazepam—Hallucination—Prednisone—systemic scleroderma	0.000422	0.00317	CcSEcCtD
Flunitrazepam—Feeling abnormal—Lisinopril—systemic scleroderma	0.000418	0.00314	CcSEcCtD
Flunitrazepam—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000416	0.00312	CcSEcCtD
Flunitrazepam—Dizziness—Azathioprine—systemic scleroderma	0.000414	0.00311	CcSEcCtD
Flunitrazepam—Asthenia—Mycophenolic acid—systemic scleroderma	0.000404	0.00304	CcSEcCtD
Flunitrazepam—CYP1A2—digestive system—systemic scleroderma	0.000397	0.0153	CbGeAlD
Flunitrazepam—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000395	0.00297	CcSEcCtD
Flunitrazepam—Drowsiness—Methotrexate—systemic scleroderma	0.000395	0.00297	CcSEcCtD
Flunitrazepam—Rash—Azathioprine—systemic scleroderma	0.000395	0.00296	CcSEcCtD
Flunitrazepam—Dermatitis—Azathioprine—systemic scleroderma	0.000394	0.00296	CcSEcCtD
Flunitrazepam—Headache—Azathioprine—systemic scleroderma	0.000392	0.00294	CcSEcCtD
Flunitrazepam—Dizziness—Leflunomide—systemic scleroderma	0.000391	0.00293	CcSEcCtD
Flunitrazepam—CYP2B6—digestive system—systemic scleroderma	0.00038	0.0147	CbGeAlD
Flunitrazepam—Sweating—Methotrexate—systemic scleroderma	0.000379	0.00284	CcSEcCtD
Flunitrazepam—CYP2C9—digestive system—systemic scleroderma	0.000377	0.0145	CbGeAlD
Flunitrazepam—Dizziness—Mycophenolic acid—systemic scleroderma	0.000373	0.0028	CcSEcCtD
Flunitrazepam—Rash—Leflunomide—systemic scleroderma	0.000373	0.0028	CcSEcCtD
Flunitrazepam—Dermatitis—Leflunomide—systemic scleroderma	0.000372	0.00279	CcSEcCtD
Flunitrazepam—Headache—Leflunomide—systemic scleroderma	0.00037	0.00278	CcSEcCtD
Flunitrazepam—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000367	0.00275	CcSEcCtD
Flunitrazepam—Asthenia—Lisinopril—systemic scleroderma	0.000364	0.00274	CcSEcCtD
Flunitrazepam—CYP2E1—digestive system—systemic scleroderma	0.000357	0.0138	CbGeAlD
Flunitrazepam—Rash—Mycophenolic acid—systemic scleroderma	0.000355	0.00267	CcSEcCtD
Flunitrazepam—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000355	0.00267	CcSEcCtD
Flunitrazepam—Headache—Mycophenolic acid—systemic scleroderma	0.000353	0.00265	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Prednisone—systemic scleroderma	0.000343	0.00257	CcSEcCtD
Flunitrazepam—CYP2E1—tendon—systemic scleroderma	0.00034	0.0131	CbGeAlD
Flunitrazepam—Agitation—Prednisone—systemic scleroderma	0.00034	0.00255	CcSEcCtD
Flunitrazepam—Angioedema—Prednisone—systemic scleroderma	0.000338	0.00253	CcSEcCtD
Flunitrazepam—Dizziness—Lisinopril—systemic scleroderma	0.000336	0.00252	CcSEcCtD
Flunitrazepam—Malaise—Prednisone—systemic scleroderma	0.000333	0.0025	CcSEcCtD
Flunitrazepam—CYP1A2—lung—systemic scleroderma	0.000331	0.0128	CbGeAlD
Flunitrazepam—Rash—Lisinopril—systemic scleroderma	0.00032	0.0024	CcSEcCtD
Flunitrazepam—Dermatitis—Lisinopril—systemic scleroderma	0.00032	0.0024	CcSEcCtD
Flunitrazepam—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000319	0.0024	CcSEcCtD
Flunitrazepam—Headache—Lisinopril—systemic scleroderma	0.000318	0.00239	CcSEcCtD
Flunitrazepam—CYP2B6—lung—systemic scleroderma	0.000318	0.0122	CbGeAlD
Flunitrazepam—Anxiety—Prednisone—systemic scleroderma	0.000313	0.00235	CcSEcCtD
Flunitrazepam—Discomfort—Prednisone—systemic scleroderma	0.000311	0.00233	CcSEcCtD
Flunitrazepam—CYP2E1—lung—systemic scleroderma	0.000298	0.0115	CbGeAlD
Flunitrazepam—Tachycardia—Prednisone—systemic scleroderma	0.000294	0.00221	CcSEcCtD
Flunitrazepam—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000294	0.00221	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Prednisone—systemic scleroderma	0.000292	0.00219	CcSEcCtD
Flunitrazepam—CYP3A4—digestive system—systemic scleroderma	0.000287	0.0111	CbGeAlD
Flunitrazepam—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000287	0.00215	CcSEcCtD
Flunitrazepam—Rash—Mycophenolate mofetil—systemic scleroderma	0.00028	0.00211	CcSEcCtD
Flunitrazepam—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00028	0.0021	CcSEcCtD
Flunitrazepam—Headache—Mycophenolate mofetil—systemic scleroderma	0.000279	0.00209	CcSEcCtD
Flunitrazepam—Malaise—Methotrexate—systemic scleroderma	0.000278	0.00209	CcSEcCtD
Flunitrazepam—Fatigue—Prednisone—systemic scleroderma	0.00026	0.00195	CcSEcCtD
Flunitrazepam—Discomfort—Methotrexate—systemic scleroderma	0.00026	0.00195	CcSEcCtD
Flunitrazepam—Confusional state—Methotrexate—systemic scleroderma	0.000254	0.00191	CcSEcCtD
Flunitrazepam—Feeling abnormal—Prednisone—systemic scleroderma	0.000248	0.00187	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000244	0.00183	CcSEcCtD
Flunitrazepam—Hypotension—Methotrexate—systemic scleroderma	0.000235	0.00177	CcSEcCtD
Flunitrazepam—Somnolence—Methotrexate—systemic scleroderma	0.000224	0.00168	CcSEcCtD
Flunitrazepam—Fatigue—Methotrexate—systemic scleroderma	0.000217	0.00163	CcSEcCtD
Flunitrazepam—Asthenia—Prednisone—systemic scleroderma	0.000216	0.00162	CcSEcCtD
Flunitrazepam—Feeling abnormal—Methotrexate—systemic scleroderma	0.000208	0.00156	CcSEcCtD
Flunitrazepam—Dizziness—Prednisone—systemic scleroderma	0.000199	0.0015	CcSEcCtD
Flunitrazepam—Rash—Prednisone—systemic scleroderma	0.00019	0.00143	CcSEcCtD
Flunitrazepam—Dermatitis—Prednisone—systemic scleroderma	0.00019	0.00143	CcSEcCtD
Flunitrazepam—Headache—Prednisone—systemic scleroderma	0.000189	0.00142	CcSEcCtD
Flunitrazepam—Asthenia—Methotrexate—systemic scleroderma	0.000181	0.00136	CcSEcCtD
Flunitrazepam—Dizziness—Methotrexate—systemic scleroderma	0.000167	0.00125	CcSEcCtD
Flunitrazepam—Rash—Methotrexate—systemic scleroderma	0.000159	0.00119	CcSEcCtD
Flunitrazepam—Dermatitis—Methotrexate—systemic scleroderma	0.000159	0.00119	CcSEcCtD
Flunitrazepam—Headache—Methotrexate—systemic scleroderma	0.000158	0.00119	CcSEcCtD
